Agnieszka Tarasik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Agnieszka Tarasik has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Andrzej Eljaszewicz
Centre of Regenerative Medicine Medical University of Bialystok Bialystok Poland
3 shared publications - Magdalena Niemira
Clinical Research Centre Medical University of Bialystok Bialystok Poland
3 shared publications - Marcin Moniuszko
Department of Allergology and Internal Medicine Medical University of Bialystok Bialystok Poland
3 shared publications - Marlena Tynecka
Centre of Regenerative Medicine Medical University of Bialystok Bialystok Poland
3 shared publications - Adam Kretowski
Clinical Research Centre, Medical University of Białystok, M. Skłodowskiej-Curie 24A, 15-276 Białystok, Poland
2 shared publications - Adrian Janucik
Centre of Regenerative Medicine Medical University of Bialystok Bialystok Poland
2 shared publications
Latest Publications
- Open Access
Heat‐Not‐Burn Tobacco Aerosols Induce Immune Dysregulation and Barrier Disruption Comparable to Conventional Cigarettes
Background: Heat‐not‐burn (HnB) tobacco products are marketed as a safer alternative to conventional cigarettes (CC), yet their health effects remain controversial, largely based on industry‐funded studies. We aimed to assess lung function in HnB and CC users and examine the mechanistic effects of HnB exposure using animal and in vitro models. Methods: Spirometry data from 650 non‐smokers (NS), 293 CC smokers, and 49 HnB users enrolled in the Bialystok‐PLUS cohort were analyzed. To investigate underlying mechanisms, a whole‐body mouse exposure model was performed with HnB aerosol or 3R4F cigarette smoke, assessing lung transcriptomic profiles (by means of RNA sequencing), lung inflammation (by flow cytometry and histochemical staining), and barrier integrity (by using immunofluorescent staining). Moreover, an in vitro ALI‐culture model of human airway epithelial cells was used to validate the mouse experiments. The effect of HnB and CC was assessed through cytotoxic effect (MTT and LDH), inflammatory responses (cytokine release by ELISA), and tight junction proteins (immunofluorescence staining). Result: Spirometric analysis (FEV1, FVC, VC) revealed no significant overall differences in lung function among HnB users, CC smokers, and non‐smokers (NS) in the unadjusted comparison. However, subgroup analyses showed that younger (< 45 years) HnB users and those with shorter smoking histories (< 20 years) already exhibited significantly lower FEV1, FVC, and VC compared to NS and CC smokers. After adjustment for age and smoking‐related covariates, HnB users displayed modest but significant reductions in static FEV1 and FVC relative to NS, while no adjusted differences were detected between HnB and CC groups, indicating comparable baseline ventilatory function. Both exposures in mice increased eosinophils and B cell counts by ~2‐fold, while decreasing ST2 + CD4 + T cells over 80%, and induced epithelial apoptosis. HnB aerosol selectively reduced basophils by almost 50%. Both HnB and CC exposure in mice caused significant epithelial damage and impaired airway barrier function, evidenced by a ~60% reduction in ZO‐1. Transcriptomic analysis revealed that CC smoke triggered a robust inflammatory gene response, whereas HnB aerosol predominantly altered metabolic pathways. In vitro, barrier function was impaired under both conditions, but cytokine secretion increased only after CC smoke exposure. Conclusion: Despite different molecular impacts, HnB aerosol exposure induces a level of airway epithelial injury and immune cell infiltration comparable to CC smoke. Our findings challenged the narrative of HnB products being a harmless alternative and highlight their potential to cause significant lung pathology.
Open AccessHeat‐Not‐Burn Tobacco Aerosols Induce Immune Dysregulation and Barrier Disruption Comparable to Conventional Cigarettes
Background: Heat‐not‐burn (HnB) tobacco products are marketed as a safer alternative to conventional cigarettes (CC), yet their health effects remain controversial, largely based on industry‐funded studies. We aimed to assess lung function in HnB and CC users and examine the mechanistic effects of HnB exposure using animal and in vitro models. Methods: Spirometry data from 650 non‐smokers (NS), 293 CC smokers, and 49 HnB users enrolled in the Bialystok‐PLUS cohort were analyzed. To investigate underlying mechanisms, a whole‐body mouse exposure model was performed with HnB aerosol or 3R4F cigarette smoke, assessing lung transcriptomic profiles (by means of RNA sequencing), lung inflammation (by flow cytometry and histochemical staining), and barrier integrity (by using immunofluorescent staining). Moreover, an in vitro ALI‐culture model of human airway epithelial cells was used to validate the mouse experiments. The effect of HnB and CC was assessed through cytotoxic effect (MTT and LDH), inflammatory responses (cytokine release by ELISA), and tight junction proteins (immunofluorescence staining). Result: Spirometric analysis (FEV1, FVC, VC) revealed no significant overall differences in lung function among HnB users, CC smokers, and non‐smokers (NS) in the unadjusted comparison. However, subgroup analyses showed that younger (< 45 years) HnB users and those with shorter smoking histories (< 20 years) already exhibited significantly lower FEV1, FVC, and VC compared to NS and CC smokers. After adjustment for age and smoking‐related covariates, HnB users displayed modest but significant reductions in static FEV1 and FVC relative to NS, while no adjusted differences were detected between HnB and CC groups, indicating comparable baseline ventilatory function. Both exposures in mice increased eosinophils and B cell counts by ~2‐fold, while decreasing ST2 + CD4 + T cells over 80%, and induced epithelial apoptosis. HnB aerosol selectively reduced basophils by almost 50%. Both HnB and CC exposure in mice caused significant epithelial damage and impaired airway barrier function, evidenced by a ~60% reduction in ZO‐1. Transcriptomic analysis revealed that CC smoke triggered a robust inflammatory gene response, whereas HnB aerosol predominantly altered metabolic pathways. In vitro, barrier function was impaired under both conditions, but cytokine secretion increased only after CC smoke exposure. Conclusion: Despite different molecular impacts, HnB aerosol exposure induces a level of airway epithelial injury and immune cell infiltration comparable to CC smoke. Our findings challenged the narrative of HnB products being a harmless alternative and highlight their potential to cause significant lung pathology.
- Open Access
Dynamic Regulation of Collagens, Proteases, Their Inhibitors, and Cell Death in Experimental Asthma in Mice
Asthma is a complex airway disorder driven by diverse immunological pathways. While type 2 (T2)‐mediated inflammation is well characterized, the mechanisms underlying T2‐low (also referred to as mixed inflammatory phenotype) or non‐T2‐mediated asthma, often associated with Th1/Th17‐driven immune responses and high pulmonary neutrophilic inflammation, remain poorly understood. This study investigates airway remodeling in acute and chronic experimental asthma models induced by house dust mite extract to elucidate inflammatory and structural changes. Two acute T2‐low models demonstrated pronounced airway inflammation characterized by goblet cell hyperplasia, collagen deposition, and significant upregulation of extracellular matrix remodeling and fibroblast activation. In contrast, the chronic Th17‐mediated model exhibited reduced ECM deposition, increased matrix metalloproteinase (MMP) activity, and a distinct molecular signature dominated by IL‐17A‐driven pathways, indicative of ECM degradation and structural instability. Furthermore, the acute models showed immune cell apoptosis as the predominant cell death mechanism. In contrast, the chronic inflammation model was marked by necroptosis localized to structural lung cells, contributing to persistent inflammation and remodeling. Our findings provide new insights into the distinct immunopathological mechanisms underlying airway remodeling and fibrosis in T2‐low and Th17‐mediated asthma phenotypes. The study emphasizes the need for advanced preclinical models and targeted therapeutic strategies to address ECM dysregulation and chronic inflammation to progress in airway remodeling treatment in asthma.
Open AccessDynamic Regulation of Collagens, Proteases, Their Inhibitors, and Cell Death in Experimental Asthma in Mice
Asthma is a complex airway disorder driven by diverse immunological pathways. While type 2 (T2)‐mediated inflammation is well characterized, the mechanisms underlying T2‐low (also referred to as mixed inflammatory phenotype) or non‐T2‐mediated asthma, often associated with Th1/Th17‐driven immune responses and high pulmonary neutrophilic inflammation, remain poorly understood. This study investigates airway remodeling in acute and chronic experimental asthma models induced by house dust mite extract to elucidate inflammatory and structural changes. Two acute T2‐low models demonstrated pronounced airway inflammation characterized by goblet cell hyperplasia, collagen deposition, and significant upregulation of extracellular matrix remodeling and fibroblast activation. In contrast, the chronic Th17‐mediated model exhibited reduced ECM deposition, increased matrix metalloproteinase (MMP) activity, and a distinct molecular signature dominated by IL‐17A‐driven pathways, indicative of ECM degradation and structural instability. Furthermore, the acute models showed immune cell apoptosis as the predominant cell death mechanism. In contrast, the chronic inflammation model was marked by necroptosis localized to structural lung cells, contributing to persistent inflammation and remodeling. Our findings provide new insights into the distinct immunopathological mechanisms underlying airway remodeling and fibrosis in T2‐low and Th17‐mediated asthma phenotypes. The study emphasizes the need for advanced preclinical models and targeted therapeutic strategies to address ECM dysregulation and chronic inflammation to progress in airway remodeling treatment in asthma.